Sino Medical Sciences Technology Inc. (688108.SS)
CNY 10.24
(-0.49%)
CNY 10.24
(-0.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 197.62 Million CNY | 66.14% |
| 2022 | 121.72 Million CNY | -15.17% |
| 2021 | 143.48 Million CNY | -45.15% |
| 2020 | 261.6 Million CNY | -27.63% |
| 2019 | 361.49 Million CNY | 15.45% |
| 2018 | 313.11 Million CNY | 15.99% |
| 2017 | 269.95 Million CNY | 18.77% |
| 2016 | 227.28 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 68.71 Million CNY | 17.74% |
| 2024 Q1 | 48.82 Million CNY | -16.91% |
| 2024 Q2 | 58.36 Million CNY | 19.52% |
| 2023 Q4 | 58.76 Million CNY | 16.72% |
| 2023 Q2 | 54.11 Million CNY | 38.72% |
| 2023 FY | 202.23 Million CNY | 66.14% |
| 2023 Q3 | 50.34 Million CNY | -6.96% |
| 2023 Q1 | 39 Million CNY | 229.33% |
| 2022 Q3 | 36.73 Million CNY | 18.86% |
| 2022 FY | 121.72 Million CNY | -15.17% |
| 2022 Q4 | 11.84 Million CNY | -67.75% |
| 2022 Q2 | 30.9 Million CNY | -26.84% |
| 2022 Q1 | 42.23 Million CNY | -30.07% |
| 2021 Q3 | 32.34 Million CNY | -2.97% |
| 2021 Q2 | 33.32 Million CNY | 91.35% |
| 2021 Q4 | 60.39 Million CNY | 86.76% |
| 2021 FY | 143.48 Million CNY | -45.15% |
| 2021 Q1 | 17.41 Million CNY | -58.14% |
| 2020 FY | 261.6 Million CNY | -27.63% |
| 2020 Q4 | 41.61 Million CNY | -48.23% |
| 2020 Q3 | 80.37 Million CNY | -1.89% |
| 2020 Q2 | 81.91 Million CNY | 41.99% |
| 2020 Q1 | 57.69 Million CNY | -43.74% |
| 2019 FY | 361.49 Million CNY | 15.45% |
| 2019 Q2 | 89.94 Million CNY | 6.58% |
| 2019 Q1 | 84.39 Million CNY | -2.09% |
| 2019 Q4 | 102.54 Million CNY | 21.2% |
| 2019 Q3 | 84.6 Million CNY | -5.94% |
| 2018 Q4 | 86.19 Million CNY | 0.0% |
| 2018 Q1 | 92.75 Million CNY | 0.0% |
| 2018 FY | 313.11 Million CNY | 15.99% |
| 2017 FY | 269.95 Million CNY | 18.77% |
| 2016 FY | 227.28 Million CNY | 0.0% |